Sign in

CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813879991
Phone
617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. 8-K Event Regulation FD disclosure · Other events
  5. 4 Planned sale Chief Scientific Officer sold 4,000 shares at $12.36 ($49,440)
  6. 144 Insider Sale of Securities
  7. 8-K Event Regulation FD disclosure · Other events
  8. 8-K Event Regulation FD disclosure · Other events
  9. 8-K Event Regulation FD disclosure · Other events
  10. 8-K Event Regulation FD disclosure · Other events
  11. 4 Planned sale Chief Scientific Officer sold 8,000 shares at $21.57 ($172,560)
  12. 144 Insider Sale of Securities
  13. 4 Planned sale Chief Scientific Officer sold 30,000 shares at $20.26 ($607,800)
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. 144 Insider Sale of Securities
  17. 8-K Event Regulation FD disclosure · Other events
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 1 of 24 · 471 filings